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A NEW ERA OF HIV: PSYCHOLOGY’S CONTRIBUTIONS TO THE EPIDEMIC AND
DEVELOPMENT OF THE PRE-EXPOSURE PROPHYLAXIS DETERMINANTS SCALE

by

CALEB CHADWICK, M.Ed.

ABSTRACT
By 1991, the Human Immunodeficiency Virus (HIV) had claimed more than 250,000 lives in
the United States (US; Chadwick, Zelaya & DeBlaere, 2017). That same year, the first clinical
trials began to test the effectiveness of Antiretroviral Treatment (ART) to combat the virus
(HIV.gov, 2017). By 1995, HIV/AIDS became the leading cause of death among Americans age
25-44 (Zuninga et al., 2008), becoming a modern epidemic of unprecedented proportions,
particularly among sexual minority men. Over time, treatments for HIV improved in their scope
and effectiveness, leading to our modern conceptualization of HIV as a chronic illness, rather
than a terminal disease. Pre-exposure prophylaxis (PrEP) is a recently developed primary
medical prevention method for HIV. Although clinical trials have demonstrated promising
results in terms of efficacy, little is known regarding the attitudes of individuals most likely to
benefit from PrEP treatment (e.g. sexual minority men). As such, the proposed study aims to
address this gap in the research literature by contributing a psychological perspective on HIV and
PrEP. Specifically, Chapter 1 provides a systemic literature review of the flagship psychological
journals associated with subfields within the discipline (e.g. counseling psychology, men and

masculinity issues, sexual orientation diversity) uniquely suited to contribute expertise relevant
to the HIV epidemic. Chapter 2 proposes to develop a scale measuring the psychosocial
determinants of PrEP utilization. Based on the extant literature, four factors are proposed for the
PrEP Determinants (PrEP-D) scale, including knowledge about PrEP, stigma, treatment
attributes, and perceived effectiveness. Results of exploratory and confirmatory factor analyses
using data collected from a sample of sexual minority men suggest the presence of four factors in
the PrEP-D scale, consistent with the themes identified in the literature. The study also provides
initial evidence of internal consistency, reliability, and construct validity.

INDEX WORDS: HIV, PrEP, Pre-Exposure Prophylaxis, Prevention, Gay, Bisexual, Sexual
Minority, Stigma
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1 PSYCHOLOGY AND HIV
Introduction
In 1993, approximately 12 years after the first diagnoses of HIV/AIDS, a group of
psychologists published a seminal call-to-action, urging psychologists to respond to the growing
health epidemic with urgency (Kelly, Murphy, Sikkema & Kalichman, 1993). Given that no
medical cure or vaccine yet existed, the authors asserted that behavior change was the primary
method of HIV prevention. This assertion uniquely positioned psychologists at the front lines of
HIV/AIDS defense (Kelly et al., 1993). The authors further urged that a new HIV/AIDS research
agenda was needed to address the needs of an escalating epidemic, offering a number of specific
priorities, including integrating the efforts of the many disciplines within psychology that might
help in primary HIV response and prevention (Kelly et al., 1993).
Now in 2017, much has changed regarding HIV. Medical treatments have advanced to the
point that HIV is no longer a terminal disease, and HIV positive individuals can live long,
healthy lives. However, it is still the case that no cure or vaccine has been developed as a
primary HIV prevention. Furthermore, the disease continues to present critical medical
consequences and has a persistent disproportionate effect on certain groups, most notably sexual
minority men (CDC, 2016). As such, in their role as behavioral scientists, psychologists remain
uniquely positioned to contribute to HIV prevention efforts. Indeed, in a statement on the role of
psychologists in the HIV/AIDS epidemic, the American Psychological Association (APA) stated
that each specialty within the discipline of psychology is relevant in research methods and
content to the issue of HIV/AIDS prevention, and psychologists are trained in a manner that
might address the multicultural nature of the epidemic and its disproportionate effect on
communities such as racial/ethnic and sexual minority men (APA, 2017a).
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As HIV/AIDS continues to evolve as a public health concern, it is important then to evaluate
how psychology has responded to this evolution, as well as to Kelly and colleagues’ (1993)
prescient call-to-action. In other words, given the long-standing call for psychologists to join the
fight against HIV/AIDS, it is important to assess whether the field has responded to its full
potential. Toward that aim, the current manuscript provides an integrative review of the HIV
literature conducted from 1993 to the present in the field of psychology. More specifically, the
current manuscript focuses on Kelly and colleagues’ (1993) specific call for the subfields of
psychology to contribute their unique expertise and focus to fight the HIV epidemic. This, in
tandem with data indicating that HIV/AIDS represents a significant health crisis for sexual
minority men in particular, suggests subfields of psychological study that may be particularly
relevant for examination would include a) counseling psychology, b) sexual orientation diversity,
and c) men’s issues. Prior to systemic review of the flagship journals associated with these three
subfields, a brief rationale for subfield relevance is provided.
Counseling Psychology
The subfield of counseling psychology is a general practice and health service provider
specialty in professional psychology (APA, 2017b). Counseling psychology strives to help
people with physical, emotional, and mental health issues across all phases of the lifespan (APA,
2017b). Even in these general terms, one could argue that counseling psychology is well-suited
to contribute to the fight against HIV, as the disease and its impact live at the intersection of
physical, emotional, and mental health. The relevance of counseling psychology becomes even
clearer in the details of its organizational mission. Specifically, counseling psychology’s
relevance to HIV can be further delineated by four organizing principals, termed pillars: 1)
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multiculturalism, 2) scholarship, engagement, and collaboration, 3) social justice and advocacy,
and 4) prevention and promotion (APA, 2017b).
Pillar I: Multiculturalism
The multiculturalism pillar is intended to support and encourage diversity across various
settings (e.g. graduate students, faculty, practitioners, researchers), as well as to expand
engagement in multicultural research and practice (APA, 2017b). Specific goals within this pillar
include: increasing research collaboration and maximizing research impact; consolidating
multicultural resources for students and practitioners; providing platforms for advocates to
address the needs of various populations; improving visibility and accessibility of current
practitioners and researchers who demonstrate multicultural competence; and continually
engaging in discourse around diversity-related current events (APA, 2017b). Indeed, with these
specific goals in mind, the pillar of multiculturalism explicitly positions the field of counseling
psychology to address the “multicultural nature of the epidemic” (APA, 2017a), particularly in
psychological research on HIV. As stated earlier, HIV has a disproportionate impact on
racial/ethnic minority communities and sexual minority men. This important area of health
disparities, the nature of which will be outlined in greater detail later in this manuscript, fits
neatly within the scope of the multiculturalism pillar. As counseling psychology is dedicated to
multicultural issues in research and practice, the subfield is ideally situated to participate in HIVspecific scholarship, engagement, and collaboration.
Pillar II: Scholarship, Engagement, and Collaboration
The pillar of scholarship, engagement, and collaboration’s intention is to build a community
of counseling psychologists who are actively collaborating in multiple fields of scholarship
(APA, 2017b). In more specific terms, the pillar is meant to promote networking and connections
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within the subfield to facilitate continued engagement in counseling psychology professional
organization involvement and service (APA, 2017b). The spirit of the pillar, however, suggests
that scholarship, engagement, and collaboration are related not only to long-term professional
success, but also to the long-term success of the discipline (APA, 2017b). Collaborating not only
within the field of psychology, but also with an interdisciplinary approach (i.e. with public
health, medical fields) would be to the benefit of counseling psychologists and counseling
psychology. Given the focus on collaborative scholarship, the potential is high for counseling
psychology to contribute to HIV research alongside fields more traditionally associated with HIV
research (i.e. public health and medical researchers) through a social justice and advocacy lens.
Pillar III: Social Justice and Advocacy
The pillar of social justice and advocacy represents a long-standing commitment from the
field of counseling psychology to actively engage in professional practices that work toward a
more just society. As a pillar of counseling psychology, the subfield aims to 1) increase
awareness of legislative issues and calls through media (i.e. listservs, social media), and 2)
promote social justice in research and practice (APA, 2017b). In line with its complementary
relationship with the pillar of multiculturalism, the HIV epidemic is a major social justice issue
in contemporary society. As a health disparities issue, and social public health concern, HIV
warrants the attention of social justice and advocacy-minded counseling psychologists. Given the
pillar’s specific promotion of social justice-oriented research, it follows that counseling
psychology might make a major contribution to psychological research on HIV, perhaps in the
form of HIV prevention research.
Pillar IV: Prevention and Promotion
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Prevention is one of the hallmarks of the field of counseling psychology (APA, 2017b). The
pillar of prevention and promotion seeks to bolster the field’s engagement in prevention-focused
scholarship (APA, 2017b). This pillar has particular resonance with Kelly and colleagues’ (1993)
call-to-action, as they asserted that psychology, as a behavioral science, was positioned to
combat HIV by helping to prevent new HIV infections via behavioral change. Given that
counseling psychology is delineated from the other fields of psychology by its prevention focus,
the subfield, perhaps more than any other subfield of psychology, should be uniquely equipped
to answer the call to produce HIV prevention scholarship.
HIV Among Sexual Minority Men
As previously referenced in the current manuscript, HIV has a disproportional impact on
sexual minority men. The overall risk for HIV infection in the United States (US) is
approximately 1 in 99 (CDC, 2016). According to the CDC, men accounted for 81% of
diagnoses of HIV infection between 2010 and 2014, as transmission rates for women overall
decreased from prior years to makeup 19% of diagnoses (2016). However, among transgender
women, rates are notably higher as on average 28% of transgender women tested positive for
HIV (CDC, 2016). Among sexual minority men, who are identified in CDC reports as men who
have sex with men (MSM), HIV transmission rates illustrate a critical disparity. Sexual minority
men are currently an alarming 83 times more likely to become infected with HIV than their
heterosexual male counterparts (CDC, 2016). These statistics illustrate not only the urgency of
the ongoing HIV epidemic, but also highlight the rationale for relevant subfields of psychology
to utilize their expertise to help combat HIV.
More directly, the identified statistics illustrate the need to focus scholarship specifically on
the health needs of sexual minority men. Given the tremendous historical and contemporary
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impact of HIV on communities of sexual minority men, the need to address HIV for this
population remains critical. Provided the stark contrast in HIV disparities, the current manuscript
takes the position of explicitly addressing HIV among sexual minority men. As such, the
subsequent literature review will only identify literature relevant to this population.
Psychological scholarship focusing on men’s issues and sexual minority communities has a
distinct opportunity to contribute pertinent focus and expertise to the HIV literature. For
example, the psychological study of masculinity might provide crucial insight into interpersonal
and intrapsychic factors that predict HIV risk among those men most effected by the epidemic
(sexual minority men). Similarly, minority stress is a major area of focus in sexual orientation
diversity research and could play a substantive role in sexual minority men’s HIV testing
behaviors and condom use, to offer only cursory potential lines of research. Indeed, it seems that
the HIV epidemic could benefit greatly from focused attention by the subfields of psychological
study mentioned here (men’s issues, and sexual minority issues), and as such should be wellrepresented within the published literature in their flagship APA journals.
Placed within the framework of a seminal call for psychologist involvement in HIV research,
and specific call to integrating the efforts of the many disciplines within psychology that might
help in primary HIV response and prevention (Kelly et al., 1993), we move to investigate how
the field has lived up to this call, with particular attention to journals that might capture the
multicultural nature of the epidemic and disproportional representation of HIV among sexual
minority men. The current systemic literature review aims to understand how the flagship
journals associated with counseling psychology (Journal of Counseling Psychology [JCP]; The
Counseling Psychologist [TCP]), men’s issues (Psychology of Men & Masculinity [PMM]), and
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sexual minority populations (Psychology of Sexual Orientation and Gender Diversity; PSOGD)
have contributed to our modern conceptualization of HIV.
Method
Search Procedures
After an initial scoping review, publication searches were carried out using electronic
database PsycINFO. PsycINFO is the American Psychological Association (APA) database for
abstracts and citations of behavioral and social science research. Various iterations of the
following terms were searched using and/or/+: “HIV,” “AIDS,” “HIV/AIDS,” “human
immunodeficiency virus,” “acquired immunodeficiency syndrome.” Search results were limited
by date (since 1993) and source journals, including “The Journal of Counseling Psychology
(JCP),” “The Counseling Psychologist (TCP),” “Psychology of Men & Masculinity (PMM),”
and “Psychology of Sexual Orientation and Gender Diversity (PSOGD).” This search yielded
621 articles. Given the focus of the current review, the researcher once again narrowed the
search to reflect only articles specific to HIV among sexual minority men, using various
iterations of the following terms using and/or/+: “gay,” “homosexual,” “bi,” “bisexual,” “sexual
minority.” This search yielded 35 articles (JCP, n = 7; TCP, n = 10; PSOGD, n = 6; PMM, n =
12). The set of articles was then screened for relevance and duplication, and were limited to peerreviewed published works that were empirical in nature, reducing total articles to 10 (JCP, n = 4;
TCP, n = 1; PSOGD, n = 3; PMM, n = 2). The final review was limited to empirical articles to
honor Kelly and colleagues’ (1993) specific identification of the need for a new research agenda
relating to HIV. Among the 25 articles not included for final review, articles were excluded for
lack of relevance to sexual minority men (e.g. studies on HIV among heterosexual men in South
Africa; n = 10), duplication (e.g. the same study identified multiple times by PsycINFO; n = 8),
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and lack of empirical nature (n = 7). Of the final 10 articles, the search identified 9 quantitative
articles, and 1 qualitative article.
Results
HIV Risk (n = 6)
In general, the literature was split by two primary areas of focus: 1) HIV risk among HIV
negative sexual minority men (n = 6), and 2) factors influencing the lives of HIV positive
individuals (n = 4). Overall, the number of articles reflected a slightly disproportional interest in
HIV risk. Of these articles, a majority of articles (n = 5) were specifically interested in sexual
risk behaviors as at least one outcome of interest.
Sexual risk behavior (n = 3). Sexual risk behavior has long been a focus of HIV
research, centering on behaviors associated with HIV risk, such as condom use, HIV testing,
serosorting, HIV status disclosure, and substance use during or prior to sexual encounters. One
study found in the systemic literature review was interested in the way minority stress moderated
the relationship between perceived social norms of HIV risk behaviors (i.e. alcohol use, tobacco
use, drug use, and sexual behavior) and reports of personal HIV risk behaviors among sexual
minority men (Hamilton & Mahalik, 2009). Indeed, their study found that the link between
perceived norms and health risk behavior was stronger for sexual minority men with high levels
of minority stress (Hamilton & Mahalik, 2009). In other words, the link between perceptions of
others’ HIV risk behaviors and sexual minority men’s own HIV risk behaviors was contingent
upon minority stress (Hamilton & Mahalik, 2009).
Another study investigated risky sexual behavior in a sample of gay and bisexual men,
using structural equation modeling to evaluate the mediating roles of substance use factors
(expectations about the sexually enhancing effects of substance use and substance use during
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sex) between internalized heterosexism (IH) and sensation seeking and unprotected anal
intercourse (Kashubeck-West & Szymanski, 2008). The study found that both substance use
factors mediated the relationship of sensation seeking to risky behaviors (Kashubeck-West &
Szymanski, 2008). Further, greater sensation seeking was related to greater expectations about
sexually enhancing effects of substances, which was in turn related to greater unprotected anal
intercourse (Kashubeck-West & Szymanski, 2008). This study illustrates the importance and
interconnection of diversity-related factors (i.e. minority stress) and HIV risk.
An additional relevant study investigated the relationship between objectification
experiences and sexual risk behaviors among sexual minority men (Watson & Dispenza, 2014).
In particular, this study assessed whether sexual objectification, objectification based on
masculine appearance norm violations, and emotions associated with these experiences predicted
sexual risk (Watson & Dispenza, 2014). Findings indicated that greater frequency of sexual
objectification, as well as positive feelings associated with sexual objectification experiences,
had a direct relationship to greater frequency of sexual risk behaviors (Watson & Dispenza,
2014). Further, negative feelings associated with masculine appearance norm violations were
also associated with greater sexual risk behaviors (Watson & Dispenza, 2014).
Body image and gender roles (n = 3). Body image and gender role identification were
of particular interest in a quantitative study on the influence of drive for masculinity and
muscularity on HIV sexual risk behaviors among sexual minority men of color (Brennan et al.,
2015). Their study found that drive for masculinity and muscularity were positively associated
with HIV sexual risk behaviors, even after controlling for sociodemographic variables and
internalized homophobia (Brennan et al., 2015). These findings suggest that disappointment with
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one’s muscularity, as well as endorsement of body image and penis size as indicators of
masculinity, may play a role in HIV risk behaviors (Brennan et al., 2015).
Another study was interested in machismo as a predictor of HIV risk among Mexican
American sexual minority men (Estrada, Rigali-Oiler, Arciniega & Tracey, 2011). The findings
suggested that machismo was not a statistically significant predictor of sexual risk behavior
(Estrada, Rigali-Oiler, Arciniega & Tracey, 2011). However, the authors did find that traditional
machismo was significantly related to STD and HIV education levels (Estrada, Rigali-Oiler,
Arciniega & Tracey, 2011). More specifically, their study found that participants reporting
higher levels of traditional machismo had lower levels of STD and HIV education than those
reporting lower levels of traditional machismo. Findings from this study highlight the
importance of considering the role of masculinity as a potential predictor of various HIV risk
factors among diverse sexual minority men.
One study was specifically interested in the predictive role of masculine gender role
conformity on HIV testing among sexual minority men (Parent, Torrey & Michaels, 2012).
Study findings indicated that heterosexual self-presentation (i.e. the desire to be perceived by
others as heterosexual) was negatively associated with HIV testing after controlling for the effect
of number of sexual partners (Parent, Torrey & Michaels, 2012). The authors assert that HIV
testing is critical in HIV prevention, and that masculine gender role conformity may impede
testing behaviors as testing may be perceived as an “outing” procedure (Parent, Torrey &
Michaels, 2012).
HIV Positive Research (n = 4)
While not as highly represented within the identified literature, some studies were not
explicitly interested in HIV risk factors. Instead, these studies focused on the experiences of HIV
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positive individuals. Each of the identified studies were either specifically or distally interested
in mental health factors among HIV positive individuals.
A quantitative study examined coping related to depression and help-seeking behaviors
among HIV positive sexual minority men (Rood, McConnell & Pantalone, 2015). In particular,
this study examined how combinations of coping strategies related to depression and HIV-related
service utilization (Rood, McConnell & Pantalone, 2015). Results suggested that individuals who
engaged in low levels of both functional (e.g. “Taking action to make the situation better”) and
dysfunctional coping strategies (e.g. “Criticizing myself”) were significantly less likely than
those who more frequently used functional strategies to engage in a range of critical HIV
services (Rood, McConnell & Pantalone, 2015). Also, participants who more frequently used
dysfunctional coping, regardless of functional coping use, reported higher levels of depression
(Rood, McConnell & Pantalone, 2015). Findings from this study underscore the importance of
coping in both mental health and HIV-specific health concerns.
Lyons and Heywood (2016) took a similar interest in mental health outcomes in their
quantitative study on collective resilience as a protective factor for the mental health and wellbeing of HIV positive sexual minority men. Specifically, their study examined whether collective
resilience is linked to better mental health outcomes among HIV positive sexual minority men
(Lyons & Heywood, 2016). Their results indicated that a high level of collective resilience was
linked to positive mental health and well-being outcomes (Lyons & Heywood, 2016). Men who
demonstrated high collective resilience were significantly less likely to report depression,
anxiety, stress, and internalized HIV stigma than men who demonstrated lower collective
resilience (Lyons & Heywood, 2016). Similarly, men who demonstrated high collective
resilience were more likely to report higher levels of well-being, life satisfaction, individual
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resilience, and overall health than lower collective resilience participants (Lyons & Heywood,
2016).
Another study extended previous research connecting substance use to negative
psychological outcomes. In this quantitative study, a higher level of methamphetamine use was
found to be associated with elevated muscularity disturbance among 97 HIV positive sexual
minority men (Jampel, Safren & Blashill, 2015). These results indicate that substance use, in this
case, the use of methamphetamines, go beyond increasing risk for HIV transmission, to having a
potential negative impact on mental and emotional health as well among HIV positive
individuals (Jampel, Safren & Blashill, 2015).
In a related, but distinct line of inquiry, one study was interested in therapist homophobia,
client sexual orientation, and source of client HIV infection as predictors of therapist reactions to
clients with HIV (Hayes & Erkis, 2000). Their study found that therapists responded with less
empathy, attributed less responsibility to the client for solving his problems, assessed the client’s
functioning to be worse, and were less willing to work with the client when the client’s source of
HIV infection was sexual, when the client was gay, and when the therapist reported higher levels
of homophobia (Hayes & Erkis, 2009). This study suggests that understanding how HIV and
sexual minority identity intersect in mental health treatment experiences could play a critical role
in both mental and HIV-related health.
Clinical Implications
The contributions from the subfields of counseling psychology, men’s issues, and sexual
orientation diversity in psychology offer considerable insight into clinical perspectives related to
HIV prevention and care. Within the subset of articles not focused on HIV positive individuals,
most identified studies focused on HIV risk factors. In this regard, it appears that clinicians
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should pay attention to several factors that play a role in determining risk for HIV, including
substance use, internalized homophobia, conformity to gender roles, sexual objectification
experiences, and body image.
Regarding alcohol and substance use, these factors may function as not only a general
health factor, but as a factor explicitly linked to HIV risk. Along these lines, clinicians might
screen regularly for substance use as part of standard clinical procedure, with particular attention
to sexual encounters during or following alcohol or substance use. Indeed, alcohol and substance
abuse have long been linked to negative mental health outcomes in their own right, and the
studies identified in the current thematic literature review illustrate that it also relates to sexual
risk behaviors, such as deciding to not wear condoms (e.g. Kashubeck-West & Szymanski,
2008). Further, among HIV positive sexual minority men, methamphetamine use was linked to
muscularity disburbance (Jampel, Safren & Blashill, 2015), which as an element of body image,
was linked to sexual risk behavior as well (e.g. Brennan et al., 2015).
In the identified literature, body image, in particular desire for muscularity, predicted
elevation in sexual risk behaviors among sexual minority men of color (Brennan et al., 2015).
Taken in concert with the Jampel, Safren, and Blashill’s (2015) findings on body image among
HIV positive men, it appears that body image is an important factor in sexual health in general,
and in HIV specific sexual health among sexual minority men. In fact, experiences of sexual
objectification, a social experience thematically related to body image, was also linked in the
identified literature to HIV sexual risk behavior (Watson & Franco, 2014). With these study
results in mind, clinicians may wish to assess for client body image when working with sexual
minority men, particularly when substance abuse is a presenting factor. Clinical interventions,
such as motivational interviewing and cognitive behavioral interventions, may prove beneficial
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in reducing client risk for HIV, promoting positive self-esteem, and ameliorating substance abuse
concerns.
Relatedly, clinicians working with sexual minority men may also find it helpful to screen
for client endorsement of traditional gender roles and masculinity. In particular, it seems that
endorsement of traditional masculinity beliefs is associated with lower levels of HIV education
(Estrada, Rigali-Oiler, Arciniega & Tracey, 2011), and desire to be perceived as prototypically
masculine is associated with lower rates of HIV testing (Parent, Torrey & Michaels, 2012). As
such, it appears that masculinity is a factor highly relevant to HIV risk among men. In particular,
it seems that social and intrapsychic alignment with traditional masculinity contributes to HIV
risk via HIV education and testing behaviors. From a clinical framework, it may be beneficial for
clinicians to be mindful of client perspectives on gender roles in light of their link to HIV related
health. Some clients may find introductions to alternative perspectives on masculinity helpful
during their time in therapy, and might be directed to resources such as The Good Men Project,
an online resource directed at contextualizing masculinity within a less-rigid, and social justiceoriented framework. Taking a social justice approach may also prove beneficial when working
with HIV positive clients as well.
In the limited research identified on HIV positive individuals, studies were aimed at
identifying factors that might predict or disrupt negative mental health outcomes among sexual
minority men, such as depression. One study found that collective resilience (Lyons & Heywood,
2016) was associated with greater personal resilience and well-being, as well as lower levels of
depression. Similarly, another study (Rood, McConnell & Pantalone, 2015) found that functional
coping strategies, characterized by items such as “Taking action to make the situation better” and
“Concentrating my efforts on doing something about the situation,” were associated with lower
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levels of depression among HIV positive participants. Both of these studies appear to reflect a
potential psychological benefit of collective action. A growing body of literature would support
this claim, as collective action has been found to buffer the discrimination→distress link (e.g.
DeBlaere, Brewster, Bertsch, DeCarlo, Kegel & Presseau, 2014), which may provide
implications for HIV positive sexual minority men, who face the intersecting minority stress
experiences associated with HIV positivity and sexual minority identification (e.g. Hamilton &
Mahalik, 2008). As such, clients may benefit from clinical interventions aimed at HIV-specific
social justice efforts, such as volunteering with local HIV service organizations. Such
interventions may be especially resonant with psychologists informed by the social justice and
advocacy pillar of counseling psychology.
Based on the research identified in the current thematic literature review, there are a
number of steps clinicians can take to promote greater HIV-related health in the community. In
particular, clinicians may contextualize or standardize substance use screenings, monitor and
intervene around issues of body image, work toward deconstructing gender role beliefs, and
promote social justice activism around HIV. While the identified literature is a helpful guide,
psychology’s role in HIV research and care may yet be defined by future directions.
Future Directions and Conclusion
Of notable absence in the current search was literature relevant to the cutting edge of HIV
prevention. More specifically, no identified research reflected the recent revolutionary medical
advancements in treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP).
Regarding TasP, researchers have estimated that the chances of transmitting HIV with an
undetectable viral load are close to zero, or perhaps even zero (CDC, 2017). These study results,
along with the development of an effective HIV prevention medication regimen (PrEP), suggest
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an exciting new era in the prevention of HIV transmission. In 2012, PrEP became the first
approved medical treatment for the prevention of HIV by the United States Food and Drug
Administration (FDA; Holmes, 2012). Although TasP and PrEP are still relatively new as
medical approaches to HIV prevention, it is essential that researchers make efforts to produce
relevant and timely research. In other words, while research on sexual risk behaviors continues to
be highly important, psychologists might also consider inquiry into TasP and PrEP to capitalize
on the momentum from promising clinical trials results. For example, research investigating
sexual minority men’s beliefs around TasP and PrEP, or psychosocial determinants of utilizing
PrEP, might bolster community interventions aimed at maximizing the effectiveness of HIV
prevention interventions. Indeed, such research efforts would fall well within the scope of the
journals identified in the current systemic literature review.
It is worth noting that psychologists are undoubtedly contributing to our knowledge in HIV
research beyond what was identified in the current literature review. The subdiscipline of health
psychology likely continues to lead the way. This is understandable, perhaps even appropriate,
but the fields of counseling psychology, and psychologists with specific interest in men’s issues
and sexual minority populations are nonetheless uniquely suited to furthering our understanding
in important ways for sexual minority men in particular, but the general population as well. With
such great potential for the subfields of psychology identified in this paper to contribute unique
focus and expertise to the HIV epidemic’s persistent effect on communities of sexual minority
men, the few articles identified in the current literature review, while substantive in content, do
not illustrate a resounding response to Kelly and colleagues’ (1993) call-to-action. Indeed, given
that HIV is one of society’s most pressing health concerns among sexual minority men, it is
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disappointing that so few articles address this area of need in psychological journals interested in
promoting health in this very community.
However, a new day has arrived in HIV research and scholarship. With the advent of TasP
and PrEP, psychologists are once again positioned on the front lines of the battle to end
HIV/AIDS. In order for TasP and PrEP to function to their full potential as HIV prevention
methods, it is critical to understand what factors make these efforts most effective and most farreaching. For example, in order for TasP to be effective, serodiscordant couples most understand
the benefits and methods to achieving undetectable HIV viral loads. Additionally, such
knowledge should tailor to the needs of the contemporary face of the HIV epidemic. More
directly, future research should address the highly disproportional effect of HIV on Black and
Latinx sexual minority men. Along these lines, I offer a statistic which once again highlights the
modern manifestation of HIV: among young men who have sex with men, Black and Latinx
communities accounted for 58% and 20% of new diagnoses within their age cohort (CDC, 2017).
This statistic provides another lens through which to consider the multicultural nature of the
epidemic and the importance of considering the influence of race/ethnicity and relevant
marginalization in the evolving nature of HIV in the US. Along these lines, psychologists can
help disseminate such knowledge, and can help the field understand what facilitates medication
adherence and other TasP concerns, along with other factors relevant to HIV prevention.
Similarly, for sexual minority men most likely to benefit from PrEP, it is a fundamental step that
mental health, public health, and medical practitioners form a scientific understanding of the
psychosocial determinants of PrEP utilization. Among those invested disciplines, psychologists
are uniquely positioned as behavioral scientists to pursue related research agendas. Indeed,
counseling psychologists as the standard-bearers of prevention scholarship and intervention in
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psychology, are a yet-untapped and invaluable resource to the HIV epidemic. While it is
certainly an exciting new day in the battle to end HIV/AIDS, the future will tell whether the
legacy of social justice in psychology extends to one of the greatest health crises in modern
history.
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2 DEVELOPMENT OF THE PRE-EXPOSURE PROPHYLAXIS DETERMINANTS
(PrEP-D) SCALE
Introduction
By 1991, the Human Immunodeficiency Virus (HIV) had claimed more than 250,000
lives in the United States (US) (Chadwick, Zelaya & DeBlaere, 2017). That same year, the first
clinical trials began to test the effectiveness of Antiretroviral Treatment (ART) to combat the
virus (HIV.gov, 2017). By 1995, HIV/AIDS became the leading cause of death among
Americans age 25-44 (Zuninga et al., 2008), becoming a modern epidemic of unprecedented
proportions, particularly among sexual minority men.
Over time, treatments for HIV improved in their scope and effectiveness, leading to our
modern conceptualization of HIV as a chronic illness, rather than a terminal disease. However,
even as a chronic illness, HIV infection, particularly when unmanaged, is associated with
numerous serious, even lethal, health concerns (e.g. heart disease, cognitive impairment, and
opportunistic infections; Ye, 2015) and remains a major focus of medical research and public
health initiatives. Further, HIV continues to have a starkly disproportional effect on sexual
minority men. The Center for Disease Control (CDC, 2016) reports that sexual minority men
continue to be the group most heavily affected by HIV in the US, estimating that while making
up only approximately four percent of the male population, sexual minority men account for
more that three-fourths (78%) of new infections among men and nearly two-thirds (63%) of new
infections overall. Although the rates of new infections among sexual minority men have
stabilized, the number of new infections among the youngest sexual minority men (age 13-24)
has increased an alarming 22% (CDC, 2016). These statistics highlight the need for future
research, particularly prevention-related research, to focus not only on sexual minority men, but
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young sexual minority men. In response to the importance of addressing the disparities in new
infection rates, as well as the efficacy of contemporary treatments for HIV, medical research foci
have partially shifted from treatment of HIV toward preventive medical interventions. This shift
in foci yielded a tremendous breakthrough with the advent of pre-exposure prophylaxis (PrEP) to
prevent HIV transmission.
PrEP became the first medical treatment approved for prevention of HIV in July, 2012
(Holmes, 2012). The CDC (2017) describes PrEP as a way for people who do not have HIV, but
are at substantial risk of getting HIV, to prevent transmission by taking a daily pill (brand name
Truvada). Truvada contains two medicines (tenofovir and emtricitabine), which are commonly
used as part of a combination treatment for HIV (CDC, 2017). When someone who is taking
PrEP is exposed to HIV, these medicines prevent HIV from establishing a permanent infection
(CDC, 2017).
PrEP Clinical Trials
PrEP has been shown to reduce risk of HIV infection among treatment-adherent
individuals considered “high risk” (Grant, Lama, Anderson & McMahan, 2010), although it is
considerably less effective when adherence levels are sub-optimal (CDC, 2017). More
specifically, the landmark iPrEx study (Grant et al., 2010) found that among gay and bisexual
men given PrEP, participants were 44% less likely overall to get HIV than those taking a
placebo. Among participants with detectable levels of PrEP in their blood (indicating treatment
adherence), PrEP reduced the risk of infection as much as 92% (Grant et al., 2010). Among
heterosexual, sexually active women and men, PrEP reduced risk of HIV infection by 62%,
although again participants infected with HIV had far less of the medication in their blood,
indicating sub-optimal treatment adherence (Thigpen et al., 2012). Among women and men who
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did not have HIV in serodiscordant couples (i.e. couples in which one partner has HIV and the
other(s) do not), those who received PrEP were 75% less likely to become HIV positive in
comparison to the placebo group (Baeten et al., 2012). Consistent with other clinical trials, for
participants in the serodiscordant couples study who were treatment adherent, PrEP reduced HIV
risk by up to 90%. No clinical trials have found any significant safety concerns with daily oral
PrEP, although some trials reported side effects such as mild upset stomach and loss of appetite
(CDC, 2017). The already encouraging effectiveness of PrEP can be further bolstered when used
with other HIV prevention methods, such as condoms (CDC, 2017), suggesting that PrEP is a
critically important new tool for preventing transmission of HIV.
A New Era of Prevention
Overall, the results from PrEP clinical trials indicate a promising new era in the treatment
and prevention of HIV. Indeed, in the updated National HIV/AIDS Strategy, updated to 2020
(HIV.gov, 2017), full access to comprehensive PrEP services for those whom it is appropriate
and desired and support for medication adherence for those using PrEP are identified areas of
recommended focus for research and public health initiatives. In efforts to implement this
strategy, the Federal Interagency Workgroup, co-chaired by the Director of the Office of
National AIDS Policy and the Director of the HHS Office of HIV/AIDS and Infectious Disease
Policy, has taken specific actions related to promoting utilization of PrEP (HIV.gov, 2017).
Specifically, the “PrEP Framework” has been developed and released to aid Federal
efforts to increase knowledge and awareness of PrEP, support its use, and identify gaps in
response efforts (HIV.gov, 2017). Of particular relevance to the current proposed study, the PrEP
Framework explicitly states that “understanding the determinants for use” of PrEP “helps target
efforts in scaling up PrEP” (HIV.gov, 2017, p. 9). Given the current study’s interest in measuring
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identified attitudes toward PrEP, results and implications should be of interest to future HIV
research and public health interventions aligned with research goals identified by the PrEP
Framework and National HIV/AIDS Strategy.
“Determinants for Use” of PrEP
In line with the National HIV/AIDS Strategy, many researchers have begun to identify
and investigate factors that appear to be “determinants for use” of PrEP. Certainly, it is still the
case that much of the PrEP research literature is oriented to medical concerns (e.g. clinical trials).
However, a growing body of research has positioned certain psychosocial factors as important
theoretically, and empirically, to the utilization of PrEP. Given the nascent state of non-medical
research (e.g. psychology research not involving clinical trials) on PrEP, this area of research has
been exploratory in nature, and therefore limited in scope, but nevertheless establishes an
essential conceptual framework for future research, which includes both potential outcomes of
interest, as well as predictors.
Outcomes
Willingness. One of the primary areas researchers have investigated relating to PrEP
utilization is devoted to understanding willingness to use PrEP. The vast majority of studies
investigating willingness to use PrEP have asked single-item yes-no questions, such as “Would
you be willing to try PrEP” (e.g. Young, Li & McDaid, 2013; Leonardi, Li & Tan, 2011). Given
that PrEP is a new, paradigm-shifting intervention, this line of inquiry has been important in
identifying whether populations considered appropriate for PrEP would be open, in the most
general of terms, to taking PrEP to prevent HIV.
One notable exception took a more nuanced approach to the construct of “willingness” as
it relates to PrEP use. In their 2012 study, Holt and colleagues used seven items to measure
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willingness, where participants responded with their agreement to statements on a 5-point Likert
scale. One example item is “I’m going to take PrEP as soon as it becomes available” (Holt, et al.,
2012). While no psychometric data other than reliability was provided or published on this scale,
it nevertheless demonstrates a need in the literature for increasingly sophisticated research
questions about PrEP utilization. In particular, this scale represents a way by which researchers
have operationalized likelihood of PrEP utilization when PrEP is appropriate. An important next
step in the literature then, is understanding and operationalizing the constructs which serve as
determinants (or predictors) of “willingness” or likelihood of using PrEP when PrEP is indicated.
Predictors
Knowledge about PrEP. HIV prevention researchers have a logical interest in
community knowledge about PrEP. A basic and necessary precursor to utilization of PrEP is
having heard of it as an HIV-prevention method. Reflecting this fundamental starting point,
initial investigations into knowledge about PrEP have focused on awareness of it as an HIVprevention tool. Specifically, much of the extant knowledge-oriented PrEP literature asks if study
participants have ever heard of PrEP or once-a-day pills to prevent HIV (e.g. Young, Li, &
McDaid, 2013). Again, as the literature extends beyond these initial and fundamental questions,
it is essential to work toward a more nuanced understanding of community knowledge of PrEP.
It seems of particular importance that the literature not only reflect awareness of PrEP, but
understanding of critical issues related to its use, such as its form (a once-daily pill),
effectiveness, and adherence-related issues. Indeed, knowledge about PrEP is not only necessary
for eventual utilization, but vital for making an informed personal choice. PrEP stigma, another
area of interest to HIV researchers, often relies on misinformation in its role as a barrier to PrEP
utilization.
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Stigma. Stigma is a widely-researched phenomenon with critical implications for the
effectiveness of PrEP’s role in the National HIV/AIDS Strategy. HIV stigma has been
consistently identified as a significant predictor of HIV testing behaviors (Earnshaw, Bogart,
Dovidio, & Williams, 2013), seeking treatment for HIV once infected (Chesney & Smith, 1999),
serostatus disclosure, and treatment adherence once treatment has begun (Mahajan et al., 2008).
Unfortunately, there is potential for parallel process in stigma predicting PrEP utilization.
Indeed, stigma could function as a barrier to PrEP utilization, and may stem from societal stigma
about sexual orientation and stigma about HIV (Jackson, et al., 2012). Along these lines, one
study (Jackson, et al., 2012) adapted items from an HIV stigma scale to assess stigma related to
taking PrEP. Sample items included, “I am concerned if I take HIV prevention medication
someone I know might see me”, and “Nurses and doctors will treat people who take the
medication as if they are contagious” (Jackson, et al., 2012). While the scale was found to be
reliable with a sample of men who have sex with men in China (Cronbach’s alpha = .86), no
further psychometric data has been published on the PrEP-adapted HIV stigma scale.
Further, while Jackson and colleagues adapted items from an HIV stigma measure, it is
important to consider how PrEP stigma might be distinct from HIV stigma. Qualitative research
has identified multiple PrEP stigmas that can differ according to particular social context (e.g.
Haire, 2015; Calabrese & Underhill, 2015). This includes the stigma of being associated with
HIV (which may also relate to other stigmas such as sexual orientation, sex work, and/or drug
use), the stigma of PrEP being perceived as a less-responsible condom alternative (Haire, 2015),
and the stigma of PrEP being perceived as a prevention method only suitable for the sexually
promiscuous (e.g. “Truvada whore”; Calabrese & Underhill, 2015). PrEP users have reported
feeling stigmatized for using PrEP by medical providers, friends, and sex partners (Liu, et al.,
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2014). In particular, PrEP users reported stigma from medical providers who are unwilling to
prescribe PrEP or appear judgmental about their decision to use PrEP, as well as stigma from
individuals who believe PrEP will lead to increased sexual risk-taking or will divert resources
away from HIV-positive people (Liu, et al., 2014). Based on the literature, it seems that PrEP
stigma, while in many ways related to HIV stigma, is a unique construct warranting distinct
measurement. In fact, PrEP stigma appears to draw not only from knowledge about PrEP, but
also from perceptions of the various attributes of treatment, such as access to PrEP (e.g. at HIV
clinics versus primary care) and required HIV testing.
Treatment attributes. Treatment attributes represent a practical challenge for
individuals considering taking PrEP to prevent HIV. Embedded within much of the research on
PrEP are inquiries related to perceived concerns for such issues. In their conjoint analysis on the
participant ratings of acceptability of PrEP, Shrestha and colleagues (2017) composed six twolevel PrEP program attributes related to overall acceptability of PrEP use: cost (insurance cost
versus out-of-pocket), side effects (none versus nausea/dizziness), efficacy of treatment (95%
versus 75%), dosing (once daily versus pro re nata [i.e. as needed]), treatment setting (HIV clinic
versus drug treatment clinic), and required frequency of HIV testing (every 6 versus every 3
months). Of the six attributes, only cost, efficacy, and side effects were found to be significantly
related to acceptability of PrEP as an HIV prevention method among participants. Similarly, one
qualitative study identified the themes of cost, side effects, adverse effects of intermittent
use/discontinuing PrEP, and general treatment accessibility as determinants of PrEP utilization
(Brooks et al., 2011). Another study whose primary aim was to evaluate willingness to take
PrEP, found that a majority of sexual minority men sampled (52.1%) were categorized as
“concerned” about taking PrEP due to specific attributes of PrEP treatment, including side
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effects and adherence requirements. Similarly, Zhou and colleagues (2012) found that concerns
for side effects and cost were significantly associated with decreased willingness to take PrEP.
Other studies have found similar results, where side effects and cost (Bauermeister et al., 2013;
Gersch et al., 2014), along with access to appropriate medical care (Hubach et al. 2017)
functioned as determinants of PrEP utilization. Taken in sum, the literature indicates that these
practical and systemic treatment-related concerns present a major consideration for people
considering PrEP. As individuals weigh financial cost, physical concerns, and personal burden
(e.g. frequent HIV testing), they will also likely take into consideration their perceptions of the
effectiveness of PrEP.
Perceived effectiveness. As indicated by the literature from PrEP clinical trials, there is
genuine reason to be optimistic about the positive influence of a once-daily pill to prevent HIV
transmission. However, the dissemination of this research may not have a straightforward
translation into public perception. Indeed, there is a documented history of difficulty translating
promising clinical trials results from other forms of HIV prevention. For example, in spite of
compelling findings supporting HIV treatment as prevention (TasP) as an effective method of
HIV prevention, research findings suggest that sexual minority men are likely to be skeptical of
TasP (Holt, 2013). Similarly, researchers utilizing the HIV Optimism/Skepticism Scale have
found variability in perceptions of the efficacy of HIV treatments, despite a legacy of findings
suggesting that HIV treatment is highly effective (Chen, 2014). We can ascertain from the
research on the perceived effectiveness of HIV treatments that people would be less likely to
take PrEP if they perceive it to be less effective (i.e. 75% vs. 95%), thus being able to identify
potential perception bias (and ultimately convey the effectiveness of PrEP) is critical. While no
such research has yet been conducted related to PrEP, history indicates that perceived
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effectiveness, regardless of research data, may function as an important determinant of PrEP
utilization.
PrEP Literature Moving Forward
Overall, in the short period of time since the advent of PrEP, the literature has made
substantial strides in clinical trials establishing efficacy, as well as in establishing an initial
screening of psychosocial factors that may determine PrEP utilization. In particular, willingness
to consider taking PrEP, PrEP knowledge, PrEP stigma, treatment attributes, and generalized
HIV treatment pessimism have received notable attention in the research literature. However,
given the stage of progress in the PrEP literature as a whole, the research to date has been
necessarily constrained in scope to initial questions intended to justify viability of implementing
PrEP on a large scale. As indicated by their shift in research focus, the National HIV/AIDS
Strategy has been convinced that PrEP is not only viable, but potentially paradigm-shifting, and
has asked the research community to work toward understanding what factors might determine
utilization of PrEP.
As PrEP continues to establish itself as a preventative intervention, it will be important to
have tools that aid in asking nuanced questions so that clinicians can better assess client concerns
and public health practitioners can develop focused, efficient community interventions. Indeed,
much of the research on determinants of PrEP use thus far has understandably come from public
health and medical researchers. However, many of the factors identified as potential
determinants of PrEP use are psychological in nature, positioning psychologists as critical front
lines investigators of these complex psychological processes. Psychology has a long and storied
history of developing the very type of psychosocial measurements needed to further the literature
on understanding the determinants of utilization of PrEP. In order to contribute to the pressing
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social justice issue that is HIV, psychologists are historically and thematically poised to make a
major contribution to the next phase of empirical research. By developing a measure of the
psychosocial determinants of utilization of PrEP, the current study aims to facilitate future
research on HIV prevention through contribution of a psychometrically-sound instrument.
The Present Studies
The purpose of the present studies is to develop the PrEP Determinants (PrEP-D) Scale to
assess four hypothesized dimensions of psychological determinants of utilization of PrEP to
prevent HIV. In Study 1, consistent with the procedures utilized in prior scale development
studies (e.g., Davis et al., 2015; Brewster et al., 2016), items will be developed on the basis of
prior literature and experts’ feedback. For Study 1, items will be administered following expert
review and subsequent revision to a sample of undergraduate sexual minority men. We will use
exploratory factor analysis (EFA) to determine the scale’s factor structure and inform initial
scale revisions, such as removing or revising items. We expect that the EFA results will provide
support for the hypothesized four-factor structure of the PrEP-D Scale. Based on prior research,
(e.g. Brooks et al., 2011; Young & McDaid, 2013), the EFA is expected to reflect dimensions of
psychological determinants of PrEP utilization, such as knowledge about PrEP (e.g. how it
works, how it is taken), stigma around PrEP use (e.g. being called a “Truvada whore”), PrEP
treatment attributes (e.g. cost, access, side effects), and perceived PrEP effectiveness. In Study 2,
we plan to replicate the factor structure based on the revised scale via confirmatory factor
analysis (CFA). Additionally, in Study 2, we will seek to provide initial evidence of construct
validity for the PrEP-D. Specifically, correlations between the PrEP-D and the AIDS Health
Beliefs Scales (AHBS, Zagumny & Brady, 1998) will be examined to establish convergent
validity. The AHBS is a measure designed to assess perceived severity of HIV/AIDS, beliefs
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around treatment benefits, HIV susceptibility, and perceived barriers to treatment (Zagumny &
Brady, 1998). In particular, I hypothesize significant positive correlations between the PrEP-D’s
perceived effectiveness and knowledge subscales and the AHBS’s benefits of prevention
subscale due to the subscales’ measurement of parallel constructs relating to awareness and
utilization of HIV prevention methods. Further, I hypothesize the stigma and treatment attributes
subscales of the PrEP-D to correlate positively and significantly with the AHBS’s barriers to
engaging in preventions subscale due to the subscales’ measurement of parallel constructs
relating to perceived impediments to HIV prevention. Given that the AHBS measures HIVspecific constructs related to treatment determinants, we believe this measure will aid in
establishing initial evidence of the PrEP-D’s validity. Detailed correlation hypotheses are
provided in Study 2 analyses.
Study 1: Exploratory Factor Analysis
Method
Participants. I recruited a national sample of 502 study participants who identified as
sexual minority men. For study 1, I split the sample randomly and used 251 of the 502 total
participants for analysis. For the entire sample, participants ranged in age from 18 to 79 years old
(M = 55.58, SD = 59, Mdn = 13.95). Approximately 84% of the sample identified as White, 8%
as Latino, 4% as African American/Black, 3% as Asian American or Pacific Islander, 1% as
Native American/American Indian, and 2% as other races or ethnicities (e.g., multiracial). In
terms of gender, 100% of participants identified as men. Regarding sexual orientation, on a 1 to
5 continuum of exclusively gay to exclusively heterosexual, approximately 84% of participants
identified as exclusively gay, 7% as mostly gay, 5% as bisexual, 2% as queer, and less than 1%
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identified as mostly heterosexual, asexual, or pansexual, and no participants identified as
exclusively heterosexual.
Approximately 32% of participants reported having earned a 4-year college degree, 29%
reported earning a professional or graduate degree (e.g., Ph.D), 24% had some college
experience, 9% had earned a high school diploma, 7% had some post-college professional or
graduate experience. Additionally, about 49% of participants self-identified as middle class, 22%
as working class, 20% as upper-middle class, 8% as lower class, and 1% as upper class.
Participants reported living in all regions of the country with about 24% residing in the
Southeast, 24% in the Southwest, 21% in the Northeast, 19% in the Midwest, 8% in the
Northwest, and less than 1% in other regions (e.g. Mid-Atlantic, US Territories). Moreover,
about 43% of participants reported residing in urban regions, 43% in suburban areas, and 14% in
rural areas of the US.
Procedure. Research participants were recruited via an Internet survey distributed by the
research engine Qualtrics. Internet surveys that are not compromised by repeat responses or
random response patterns have been found to provide results comparable to those from pen-andpaper surveys (Gosling, Vazire, Srivastava, & John, 2004). Through partial funding from
Georgia State University’s Hayden-Waltz Doctoral Dissertation Award, Qualtrics recruited all
study participants. Qualtrics utilizes a proprietary computer software program that automates the
process of conducting surveys, including participant identification and recruitment. Participants
are typically chosen from pre-arranged pools of respondents who have agreed to be contacted for
participation in surveys, polls, and market research. Participants were compensated by Qualtrics
for their participation at a cost of $6 per participant. Prior to beginning the survey, participants
were administered an informed consent, which provided details on the purpose of the study (i.e.,
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understanding attitudes toward PrEP), informed of study inclusion criteria (i.e., 18 years of age,
reside in North America, identify as a sexual minority male), study measures, and a debriefing
form. After being asked an inclusionary question on eligibility, participants were directed to the
survey instrument. The current study is interested in the perceptions of sexual minority men,
therefore, participants who did not identify as such were excluded. The survey took
approximately 30 minutes to complete. The survey also included three validity questions placed
throughout the survey (e.g., “please respond strongly disagree”) to identify errant or random
responding.
Instruments.
Development of the PrEP-D Scale. A pool of items was developed to assess potential
determinants of utilization of PrEP. Item development was informed by prior literature on PrEP
attitudes and barriers, including qualitative and quantitative articles describing perceptions of
PrEP by sexual minority men (e.g. Holt et al., 2013; Saberi et al, 2012; Young & McDaid, 2012),
and theoretical and empirical scholarship addressing implementing PrEP as prevention to HIV
(e.g. Shrestha et al., 2017; HIV.gov, 2017; Whiteside et al., 2011). Initial items in the pool were
developed to reflect themes identified in this literature (i.e. knowledge about PrEP [n = 19], PrEP
stigma [n = 17], perceived effectiveness of PrEP [n = 16], and treatment attributes of PrEP [n =
20]). This pool of 72 items was then reviewed by six experts on HIV and PrEP (i.e., social and
medical science faculty members and doctoral researchers whose programs of research address
issues of HIV and HIV prevention, including PrEP) and scale development. These expert
reviewers provided feedback about item clarity, content validity, and item construction and also
made suggestions for expansion and deletion of items.

34

Following incorporation of proposed revisions and deletions, the final item pool included
71 items for inclusion in Study 1. Respondents were asked to reflect on statements (e.g., “PrEP is
only for people who are careless”) and asked to report their level of agreement with that
statement on a 7-point Likert scale (1 = strongly agree to 7 = strongly disagree).
Results
Prior to randomly splitting the dataset for conducting primary analyses, data were
evaluated for missingness, normality assumptions, and suitability for factor analysis. Regarding
missingness, no data were missing from the current sample. The researcher also examined
possible violations of normality assumptions, and the data met recommendations at the
univariate (e.g. skewness > 3.00 and kurtosis > 10.00; Weston & Gore, 2006) level.
Regarding multivariate normality, no cases were identified as multivariate outliers when
inspecting Mahalanobis distances (ps < .001; Tabachnick & Fidell, 2007). Further, a KaiserMeyer-Olkin value above .90 (.92; Tabachnick & Fidell, 2001) and significant Bartlett’s tests of
sphericity 2 = 20146.08, p < .001 (George & Mallery, 2009; Tabachnick & Fidell, 2001)
indicated that the data were suitable for EFA.
An initial EFA analyzing the correlation matrix of the PrEP-D scale was conducted using
no rotation and no specified number of factors for retention. Multiple criteria were evaluated to
determine the structure of the PrEP-D, including Kaiser’s rule, evaluation of the scree plot, and
parallel analyses. Regarding Kaiser’s rule (Kaiser, 1960), factors with eigenvalues greater than
one are recommended for retention (Pituch & Stevens, 2016). For the current study, 15 factors
had eigenvalues greater than one. The scree plot was also examined, and following the
recommendation to retain all eigenvalues in the sharp descent prior to the first factor in the line
where the eigenvalues level off (Cattell, 1966), three factors were indicated for retention. Parallel
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analysis was also conducted and supported a five-factor solution. Parallel analysis compares the
eigenvalues of the existing dataset to those of 1,000 randomly generated datasets. One retains
factors until the next eigenvalue (in this case the sixth factor) explains less than the eigenvalue of
the randomly generated dataset. More specifically, in the current study the eigenvalues for the
first five factors were higher in the actual dataset (i.e., 15.38, 8.95, 3.74, 2.78, 2.63) than in the
parallel analysis (i.e., 2.3, 2.18, 2.09, 1.95, 1.9), which argues for retention of the first five
factors. Next, communalities were examined and items that moderately related (i.e.,
communalities less than .5) to each other after controlling for the total score on the latent
construct were dropped (Funk & Rogge, 2007), resulting in removal of 8 items with
communalities ranging from .42 to .501. Taken together, I proceeded with testing the retention of
three to five factors for the PrEP-D scale.
Three to five factor models were examined utilizing principal axis factoring (PAF) with
promax rotation. An oblique rotation was utilized because I anticipated that the factors would be
correlated (Worthington & Whitaker, 2006). Each of the models were evaluated based on
meaningfulness and interpretability of the identified factors, as well as item-retention criteria
intended to promote internal consistency reliability (DeVellis, 2003). In particular, at this stage
of scale development, each factor needed to have at least 3 items to be retained. First, an EFA
was conducted specifying a five-factor solution. The five-factor solution provided five
interpretable factors and explained 52.80% of the variance. However, the fifth factor had only
one item loading at least .50 on the latent construct, indicating that the five-factor solution does
not meet criteria for simple solutions, thus suggesting that five or more factors are not indicated

Analyses were also run including the items removed due to communalities. The results indicated equivalent
findings in terms of factor retention (the fifth factor had only two items loading at least .50 on the latent
construct), but resulted in poorer subsequent model fit. As such, removing items due to communalities was
included in final analyses.
1
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for retention. Next, an EFA was conducted specifying a four-factor solution. The four-factor
solution provided four interpretable factors with at least three items per factor and explained 49%
of the variance. Item factor loadings ranged from .36 to .82 (Factor 1), .49 to .88 (Factor 2), .34
to .9 (Factor 3), and .31 to .81 (Factor 4). Similarly, an EFA was conducted specifying a threefactor solution, which provided three interpretable factors with at least three items per factor. The
three-factor solution explained 44.71% of the variance. Item factor loadings ranged from .45 to
.75 (Factor 1), -.3 to .78 (Factor 2), and .47 to .88 (Factor 3). Given that the three-factor solution
explained less of the total variance, indicated negative items loadings on primary factors, and
that the factor loadings were generally higher for the four-factor solution, the findings of this
initial evaluation of the factor structures suggested a four-factor solution for the PrEP-D.
Additionally, the body of literature suggests that choosing to retain more factors than are needed
is less detrimental to the analysis than eliminating factors that are needed (e.g. Pett et al., 2003),
further supporting a four-factor solution for the PrEP-D.
Next, the pattern coefficients for the four-factor solution were examined for magnitude of
item factor loadings and cross-loadings. Items were dropped (n = 39) if they did not load at least
.50 on their primary factor or had a cross-loading over .25 on any secondary factor (Factor 1 (n =
12), Factor 3 (n = 2), and Factor 4 (n = 2), DeVellis, 2003), resulting in retention of 32 items. As
can be seen in Table 1, the range of item loadings for Factor 1 was .57 to .83, Factor 2 was.57 to
.88, Factor 3 was.52 to .90, and Factor 4 was.54 to .81. The items with the highest loadings for
each factor supported the theorized dimensions of Knowledge About PrEP: “I am well-educated
on PrEP”; PrEP Stigma: “Taking PrEP might make people think less of me”; Treatment
Attributes: “I am concerned about my access to PrEP treatment”; and Perceived Effectiveness:
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“I am confident PrEP will reduce my chances of becoming HIV positive.” The final factors
accounted for 24.52%, 14.09%, 6.10%, and 4.29% of the variance in items, respectively.
To establish a final version of the PrEP-D, I ran a Pre-CFA using Mplus (Version 6.11) to
ensure the identified model provides an acceptable fit to the data. Further, the Pre-CFA
facilitated creating a more parsimonious model by identifying items for removal and improving
model fit. First, using the version of the PrEP-D established in prior steps of Study 1, items were
constrained to load on their respective factors. Model fit was determined through the use of
absolute and incremental fit indices: the comparative fit index (CFI), the standardized root-meansquare residual (SRMR), the root mean square error of approximation (RMSEA), and χ2.
According to Weston and Gore (2006) in their review of model fit guidelines, the criteria for
acceptable fit are CFI  .90 and RMSEA and SRMR  .10 (e.g. Hu & Bentler, 1995) with more
stringent criteria of CFI  .95, and RMSEA  .05 (e.g. Hu & Bentler, 1999; Quintana &
Maxwell, 1999). The model provided an acceptable fit to the data (CFA = .93; RMSEA = .09,
90% confidence interval (CI) [.09 .1]; SRMR = .08; χ2 = 1077.09, p < .001). Modification
indices (i.e. change of chi-square in a model if a parameter is changed), which are provided in
the output of the Pre-CFA analyses, were followed to identify items for removal (n = 16) to help
create a more parsimonious and better-fitting model. More specifically, items were selected due
to high potential improvement to the model’s chi-square, and CFAs were run iteratively to
evaluate model fit to the data without the respective item in order to identify the most
parsimonious and best fitting model to the data. Figure 1 provides an overview of item retention
process. Using the final version of the PrEP-D, I ran a final Pre-CFA to determine model fit, and
the four-factor model provided a good fit to the data (CFA = .98; RMSEA = .07, 90% confidence
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interval (CI) [.06 .08]; SRMR = .05; χ2 = 218.15, p < .001). For Study 1, internal consistency
reliabilities for the four factors were .83, .81, .89, and .83 respectively.
Study 2: Confirmatory Factor Analysis
Method
Participants and procedure. Study 2 utilized the same recruitment procedure,
methodology, and data cleaning procedures described in Study 1. We utilized the remaining 251
participants for Study 2. To control for order effects, the order of measures was randomized.
Measures
PrEP Determinants Scale (PrEP-D). To confirm the factor structure and model-based
reliability results obtained in Study 1, Study 2 includes items from the final version of the PrEPD. Scores are generated by computing means scores for each of the 4 subscales. Due to the
valence of the 7-point Likert scale (1 = strongly agree to 7 = strongly disagree), all items are
reverse scored to aid in interpretation of correlations between the PrEP-D and AHBS subscales.
As such, higher scores for the subscales indicate higher levels of knowledge about PrEP, greater
PrEP stigma, higher levels of concern regarding treatment attributes, and higher levels of
perceived effectiveness.
AIDS Health Belief Scale. The AIDS Health Belief Scale (AHBS, Zagumny & Brady,
1998) is a 16-item scale developed to measure the four components of the Health Belief Model
as they relate to HIV/AIDS (i.e., Perceived Severity of Contracting HIV, Perceived Benefits of
Prevention Methods, Perceived Susceptibility to Contract HIV, and Perceived Barriers to
Engaging in HIV Prevention Behaviors), although only Perceived Benefits of Prevention
Methods and Perceived Barriers to Engaging in HIV Prevention Behaviors subscales were
utilized in the current study. Participants are asked to respond to AHBS items on a six-point
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Likert scale ranging from (1 = strongly disagree to 6 = strongly agree), where there is no neutral
option. The AHBS generates a total score in addition to scores for each of the subscales; higher
scores indicate higher HIV-related health beliefs. Example items from each subscale of the
AHBS include: “I believe that the chances of contracting AIDS can be significantly reduced by
using a condom.” (perceived benefits); “It is embarrassing (to me) to buy condoms.” (perceived
barriers). High internal consistency reliabilities have been found among samples of university
students for both of the subscales used in the current study: Perceived Benefits of Prevention
Methods (α = .93), and Barriers to Engaging in HIV Prevention Behaviors (α = .92; Zagumny &
Brady, 1998). Regarding validity, both of the utilized AHBS subscale scores have been found to
correlate significantly (Benefits of Prevention positively; Barriers to Engaging negatively) with a
measure of attitudes toward condom use (Scandell & Wlazelek, 2002). Internal consistency
reliabilities were found to range from adequate to acceptable for the barriers to prevention (α =
.63) and benefits of prevention (α = .73) subscales.
Results
The purposes of Study 2 were to (a) confirm the factor structure of the PrEP-D Scale
using a national sample of sexual minority men, (b) provide evidence of internal consistency
reliability of the PrEP-D, and (c) provide initial evidence of construct validity of the PrEP-D
Scale.
To confirm the factor structure of the PrEP-D, CFA was conducted using Mplus (Version
6.11). Using the version of the PrEP-D determined in the prior study, items were constrained to
load on the factors identified in Study 1. As in Study 1, model fit was determined through the use
of absolute and incremental fit indices: CFI, SRMR, RMSEA, and χ2. In accordance with model
fit guidelines guidelines (Weston & Gore, 2006; Hu & Bentler, 1995; Quintana & Maxwell,
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1999) , the four-factor model provided a good fit to the data (CFI = .99; RMSEA = .06, 90%
confidence interval (CI) [.05, .07]; SRMR = .04; χ2 = 189.44, p < .001). Factor loadings, which
are detailed in Table 2 along with standard error terms, were all statistically significant and
standardized values ranged from .61 to .97. For the current study, the internal consistency
reliabilities for the PrEP-D’s subscales were as follows: Perceived Effectiveness (α = .83),
Knowledge (α = .80), Stigma (α = .89), Treatment Attributes (α = .83). Thus, the results of Study
2 supported the four-factor structure and internal consistency of the PrEP-D.
Regarding construct validity of the PrEP-D, correlations between the final version of the
PrEP-D scale and the AHBS were examined. In particular, the researcher hypothesized positive,
statistically significant correlations between the PrEP-D’s Perceived Effectiveness and
Knowledge subscales and the AHBS’s Benefits of Prevention (M = 4.99; SD = .83) subscale. In
the current study, the AHBS’s Benefits of Prevention subscale was significantly correlated with
the Perceived Effectiveness subscale (r = .11; p < .05), but not the Knowledge subscale (r = -.01;
p = .55). Further, the researcher hypothesized the Stigma and Treatment Attributes subscales of
the PrEP-D would correlate positively and significantly with the AHBS’s Barriers to Engaging in
Prevention (M = 2.; SD = .84) subscale. As hypothesized, the PrEP-D’s Stigma (r = .24; p <
.001) and Treatment Attributes subscales (r = .19 ;p < .001) were significantly and positively
correlated with the AHBS’s Barriers to Engaging in Prevention subscale. Because the factor
structure obtained in Study 1 was confirmed in Study 2, descriptive statistics are reported for the
total sample in Table 3.
Discussion
The present studies seek to contribute to the national effort to fight HIV by providing a
formalized, psychometrically sound instrument to facilitate inquiry into the factors that
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determine utilization of PrEP to prevent HIV. With the Pre-Exposure Prophylaxis Determinants
(PrEP-D) Scale as a tool, researchers invested in preventing HIV can work toward understanding
the psychosocial nuances of PrEP-related decision making. With that understanding in place at
local and national levels, intervention and outreach efforts can be more focused, efficient, and
effective at reaching targeted populations with targeted messaging. In other words, the PrEP-D
Scale can be used to help get PrEP to those who might most benefit.
In the present studies, we developed the PrEP-D Scale and used factor analysis to
determine and replicate the scale’s factor structure. In Study 1, results supported the theorized
four-factor structure. Also as theorized, the four factors represent key psychosocial elements
(knowledge about PrEP, PrEP stigma, treatment attributes, and perceived effectiveness) that may
determine PrEP utilization. As noted previously, the highest loading items for each factor
provides a helpful indication of the nature of each latent construct, including Knowledge About
PrEP: “I am well-educated on PrEP”; PrEP Stigma: “Taking PrEP might make people think less
of me”; Treatment Attributes: “I am concerned about my access to PrEP treatment”; Perceived
Effectiveness: “I am confident PrEP will reduce my chances of becoming HIV positive.”
Regarding subscale intercorrelations for the PrEP-D, I anticipated significant correlations
between the PrEP-D’s four factors. However, the Treatment Attributes subscale was not found to
correlate significantly with the Knowledge About PrEP subscale. Although this was unexpected,
the Treatment Attributes may be measuring a construct with a notable difference from the
Knowledge About PrEP subscale. In particular, the Knowledge subscale focuses on participants’
understanding and awareness of PrEP as a medication/treatment. In contrast, the Treatment
Attributes items focus considerably on concerns related to the systems around PrEP that are
ultimately independent of the medication/treatment itself (i.e. health insurance security,
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providers’ knowledge about PrEP). As such, the relationship between those two factors may not
have been strong enough to reach statistical significance. The Stigma and Perceived
Effectiveness subscales, both of which correlate with each of the other subscales, share
characteristics with both sides of this divide. In particular, they are oriented to PrEP
medication/treatment specific foci (i.e. concerns around others seeing the medication [Stigma];
believing the medication could work for them [Perceived Effectiveness] and on systems concerns
(i.e. being treated differently by doctors and nurses [Stigma]; believing that PrEP is viable in the
longterm [Perceived Effectiveness]). I believe this conceptual variance in identifying personal,
PrEP-specific, and systems-related determinants of PrEP is a particular strength of the scale. It
should also be noted that since all of the subscales do not correlate, generation of total scores is
not indicated for the PrEP-D2. However, the pattern of correlations present an unexpected, but
potentially useful conceptual distinction between the PrEP-D’s factors. More specifically, the
Perceived Effectiveness and Knowledge subscales are significantly and positively correlated (r =
.43; p < .001), and a similar relationship was found between the Stigma and Treatment Attributes
subscales (r = .49; p < .001). Further, the negative correlations between the first grouping
(Perceived Effectiveness and Knowledge) and the second grouping (Stigma and Treatment
Attributes) suggest the possibility that these groupings of factors might have a useful, additional
layer of interpretability. In particular, the two groupings of factors might represent factors that
indicate and counter-indicate use of PrEP to prevent HIV3.

A general higher order model was tested using CFA to further assess the appropriateness of generating a
total score for the PrEP-D. However, the model did not provide a good fit to the data (CFI = .89; RMSEA = .11,
90% confidence interval (CI) [.10, .12]; SRMR = .11; χ2 = 1931.59, p < .001).
3 An additional higher order model was tested using CFA to assess the appropriateness of generating two
additional scores: a) PrEP Indicated, and b) PrEP Counter-Indicated. The model provided an adequate fit to
the data (CFI = .93; RMSEA = .09, 90% confidence interval (CI) [.08, .10]; SRMR = .08; χ2 = 1375.26, p < .001).
2
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The stability of the scale’s structure was supported by CFA in Study 2. Further, in Study
2, further evidence was provided for the PrEP-D’s internal consistency reliability and initial
support for construct validity was obtained. More specifically, the PrEP-D demonstrated
adequate internal consistency reliability and its items are face-valid. However, contrary to the
hypotheses, the analyses utilizing the AHBS measure provided inconsistent evidence of construct
validity. Although the findings suggested that the PrEP Stigma and Treatment Attributes
subscales correlated with the Barriers to Treatment subscale, the lower internal consistency
reliability value for the Barriers to Treatment subscale was unexpected. Scores for the Barriers to
Treatment subscale were found to be generally consistent with the current study’s sample (M =
2.29; SD = .84) when compared to findings reported with the instrument development sample (M
= 2.90; SD not reported), and the internal consistency reliability falls within the range of
“adequate,” “satisfactory,” or “sufficient,” particularly when a scale has as few items (n = 4) as
the Barriers to Treatment subscale (Taber, 2018). Further, although the AHBS’s Benefits of
Prevention was found to have acceptable internal consistency reliability, it was only found to
correlate significantly with the Perceived Effectiveness subscale, but not the Knowledge About
PrEP subscale. In contrast to prior findings, the Benefits of Prevention subscale was found to
have higher means scores by more than 1 standard deviation for the current sample (M = 4.99;
SD = .83) than the instrument development sample for the AHBS (M = 4.13; SD not reported).
This finding appears to suggest that the current sample has a generally higher estimation of the
benefits of engaging in HIV prevention efforts than did the sample used to develop the AHBS.
Although no clear conclusions were identified regarding the unexpected findings for the AHBS’s
performance and relationship to the PrEP-D, the author offers two potential factors that may
have influenced these findings: 1) sample demographics and 2) temporal context. First, in regard
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to sample demographics, the AHBS was developed utilizing a sample of mixed-gender
undergraduate students and does not report sample sexual orientation. These demographic
characteristics contrast the current sample in regard to age, gender, and presumably sexual
orientation. Such considerations, particularly given the disproportional impact of HIV on sexual
minority men, could result in discrepant patterns in item response between the two samples.
Second, regarding temporal context, the nature of HIV and the semantics used when discussing
HIV have changed considerably since the AHBS was developed. The AHBS, which was
developed in 1998, utilizes language that represents a different social and medical context for
HIV/AIDS. Much of the scale utilizes language specifically pertaining to AIDS (as opposed to
HIV) and includes items that contrast to the modern conceptualization of HIV as a chronic
illness, rather than a lethal diagnosis. One such item “I would rather have any terminal illness
than AIDS” offers a particularly strong example of this concern. Such items may have elicited
reactions from participants in the current study at both cognitive (e.g. confusion) and emotional
(e.g. anger) levels that may have led to response patterns that may differ from responses patterns
obtained from the time the AHBS was developed. As such, more evidence of construct validity
for the PrEP-D is needed. Once such evidence is obtained through future research, the PrEP-D
should provide a much-needed tool for clinical and research endeavors relating to HIV
prevention.
Each of the PrEP-D’s subscales has distinct utility. Researchers and professionals who
focus on public health awareness may be particularly interested in the Knowledge About PrEP or
Perceived Effectiveness subscales. Indeed, it may prove critical to know which communities
indicate less PrEP awareness or lower perceptions of PrEP’s ability to reduce HIV risk. Tailored
and targeted education and awareness initiatives could help such professionals to specifically
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address one of the modern HIV epidemic’s most confounding challenges: disproportional rates
of HIV among Black and Latino sexual minority men. For example, using the PrEP-D as an
investigatory tool, future research might find that Black sexual minority men in the Southeast
region of the US might indicate lower levels of perceived effectiveness while indicating levels of
knowledge that suggest saturation of interventions aimed at raising awareness. If this were the
case, organizations could begin to shift their research efforts from raising awareness to
addressing factors that reduce perceived effectiveness (e.g. systemic concerns relating to trust of
medical providers; disseminating more personalizable or relevant research findings).
The Treatment Attributes subscale may be of particular interest to policy makers or to
those with investment in systemic concerns in public health. Targeted interventions around
ameliorating treatment attributes concerns (i.e. cost, access), may be crucial in helping get PrEP
to those who would most benefit. Parallel to other subscales, having a better understanding of
which groups of individuals express higher levels of treatment attribute concerns could
particularly help streamlining policy and public-health efforts. For example, if some specific
geographic (i.e. rural) areas indicate higher levels of concern about treatment attributes, efforts
could be made to make PrEP more easily accessed for those communities. Mobile PrEP clinics
could be piloted to help bring the doctor and medication to such communities. Such efforts
would be more feasible and cost-effective with more specific information on who is concerned
about the attributes of PrEP treatment. The PrEP-D offers a potentially potent tool in such
efforts.
Similarly, with a better understanding of PrEP stigma (and who it most effects), strides
could be made in mediating the degree to which PrEP stigma functions as a barrier to HIV
prevention. For example, medical professionals such as nurses and doctors may wish to discuss

46

stigma-related concerns when consulting with their patients about their sexual health and may
choose to develop strategies for navigating such stigmas (e.g. patients choosing to “disguise”
medications to avoid being outed or experiencing stigma/rejection; strategically selecting checkup appointment times and locations to avoid peak-hours or encountering individuals that could
recognize the patient). Along these lines, mental health professionals may be particularly wellsuited to intervening around PrEP stigma and could help to ameliorate internalized stigma and
develop functional strategies for tolerating experienced stigma and avoiding stigmatizing
experiences when possible and appropriate. Given the potential clinical utility of the PrEP
Stigma subscale, clinicians may wish to use the PrEP Stigma subscale as a screening item in
settings with a particular interest in sexual health or HIV prevention. Similarly, researchers can
facilitate clinical efforts by designing research to help understand how PrEP Stigma functions as
a predictor of PrEP utilization. For PrEP Stigma, as with each of the PrEP-D subscales,
understanding how, for whom, and to what degree these subscales/constructs lead to more
optimal utilization of HIV prevention strategies is essential to improving HIV prevention efforts
and moving toward an HIV-free generation.
It is within this context of providing practical insight around PrEP utilization that
potential for the PrEP-D becomes clearest. The unexpected exploratory finding regarding
generating PrEP Indicated and PrEP Counter-Indicated scores highlights the PrEP-D’s potential
utility. Researchers and public health officials could assess whether their communities might
benefit from PrEP-related outreach and intervention. Clinicians could assess individual patients
for the appropriateness of PrEP intervention. Put plainly, invested parties could have a clear way
to identify whether PrEP is a good idea. Then, given the nature of the identified subscales, those
same invested parties can make efficient investments in either raising PrEP knowledge and
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awareness, intervening around accurate perceptions of PrEP’s effectiveness, reducing PrEPrelated stigma, or ameliorating concerns around access and other treatment attributes. In this
regard, the PrEP-D could be a powerful tool in the fight to end HIV and reduced HIV disparities.
Limitations and Future Research
The present studies had several limitations. First, although a major asset of the present
studies was a national sample of sexual minority men, the sample was predominantly White and
the average age was higher than the average age in the United States. As such, a crucial next step
is to establish norms on targeted samples. Given the disproportional rates of HIV in the United
States, it seems especially important to establish norms among young Black and Latino sexual
minority men. It is important to note as well that Black women are also at significant and rising
risk for HIV, and they are not represented in the current studies.
A similar second limitation of the current study was that participants were recruited via
online survey and as such represent only those sexual minority men who were identified by
recruitment and felt motivated enough to participate. This is a well-documented challenge in
HIV-prevention research, where it is often an aspect of marginalization that some individuals are
not identified during research recruitment or may not wish to participate. For example,
individuals with high levels of a variety of stigma concerns (e.g. sexual orientation, HIV, PrEP)
may interpret research participation as a potential avenue for experiencing stigmatization such as
being “outed.” Although these concerns are difficult to avoid, future research may wish to utilize
clinical samples in partnership with organizations engaging in face-to-face HIV prevention
efforts (e.g. AID Atlanta; Howard Brown Health Center).
Third, the current studies use a cross-sectional, correlational design, which is a common
standard in scale-development studies that use EFA, CFA, and validity analyses. However, given
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that the PrEP-D scale is intended to measure what determines utilization of PrEP, a logical next
step would involve longitudinal design. For example, it would be highly informative for a future
study to investigate among PrEP-naïve individuals which of the subscales are dynamic over time,
as well as how changes in subscale score might relate to observed PrEP uptake among study
participants. Along these lines, future research might use experimental designs to explore how
intervention across the factors related to PrEP use (e.g. workshops on navigating stigma;
alternative service delivery locations; PrEP peer counseling) might lead to subsequent PrEP
utilization.
Conclusion
Overall, the present studies offer the PrEP-D as a new and essential tool in helping
researchers and clinicians work toward optimizing the effectiveness of HIV prevention efforts.
By systematizing inquiry into the factors associated with PrEP utilization, we can move toward a
better understanding of what might predict the effectiveness of PrEP, one of the most
revolutionary developments in the fight to end HIV. Importantly, the PrEP-D will help the field
understand the nature and function of knowledge about PrEP, PrEP stigma, the attributes of PrEP
treatment, and the perception of PrEP’s effectiveness. Perhaps even more critically, it can also
help illuminate how and why there are still some marginalized groups of sexual minority men
firmly at the epicenter of the modern HIV epidemic. With this in mind, it is my greatest hope that
the PrEP-D can be a tool for reducing the disproportional impact of HIV on sexual minority men
(particularly Black and Latino sexual minority men) and move the community one step closer to
an HIV-free generation.
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APPENDICES
Appendix A
Table 1
EFA Four-Factor Solution of the PrEP-D
PrEP-D Items
44. I am confident PrEP will reduce my chances of becoming HIV
positive
43. Taking PrEP will protect me from becoming HIV-positive
50. PrEP is effective enough for me
45. PrEP is not a good longterm option for me
38. PrEP would not work for me
36. PrEP is effective at preventing HIV
61. I am well-educated on PrEP
62. I am familiar with the possible side-effects of PrEP
64. I am able to educate others on PrEP
63. I know how to access PrEP treatment
60. I am well-educated on HIV
51. I am familiar with the research on PrEP to prevent HIV
2. Prior to this survey I was familiar with the term PrEP
59. I have noticed advertisements on PrEP in my community
58. I have noticed advertisements on PrEP in the media
57. I have talked with friends about PrEP
1. Prior to taking this survey I had heard of a once daily medication to
prevent HIV
11. Taking PrEP might make people think less of me
12. People will treat me differently if I am on PrEP
4. I am worried people would think I am promiscuous if they knew I
were taking PrEP
15. PrEP will lead to increased risky sexual behaviors in my community

Perceived
Effectiveness
.82

Knowledge
About PrEP

PrEP
Stigma

Treatment
Attributes

.79
.74
.72
.60
.57
.88
.87
.81
.72
.66
.66
.65
.61
.59
.58
.57
.90
.89
.73
.73
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9. People will consider me a Truvada whore if they knew I were taking
PrEP
13. Potential partners will reject me if I take PrEP
10. I wouldn’t trust someone who took PrEP
5. PrEP is only for people who are careless
7. Nurses and doctors might treat me differently if they knew I were
taking PrEP
3. I am worried people would think I’m HIV positive if they knew I were
taking PrEP
32. I am concerned about my access to PrEP treatment
31. I worry that my medical provider may not be willing to prescribe
PrEP
29. I worry about taking PrEP and then having a lapse in insurance
coverage
30. I am concerned that my medical provider may not be educated about
PrEP
35. I would take PrEP if it weren’t for the side effects

.69
.67
.66
.59
.58
.52
.81
.70
.67
.62
.54
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Appendix B
Table 2
CFA Standardized Factor Loadings and Standard Error
PrEP-D Items
Factor 1
44. I am confident PrEP will reduce my chances of becoming HIV positive
36. PrEP is effective at preventing HIV
43. Taking PrEP will protect me from becoming HIV-positive
50. PrEP is effective enough for me
Factor 2
61. I am well-educated on PrEP
64. I am able to educate others on PrEP
58. I have noticed advertisements on PrEP in the media
60. I am well-educated on HIV
Factor 3
12. People will treat me differently if I am on PrEP
11. Taking PrEP might make people think less of me
9. People will consider me a Truvada whore if they knew I were taking PrEP
4. I am worried people would think I am promiscuous if they knew I were
taking PrEP
Factor 4
31. I worry that my medical provider might not be willing to prescribe PrEP
32. I am concerned about my access to PrEP treatment
30. I am concerned that my medical provider may not be educated about PrEP
29. I worry about taking PrEP and then having a lapse in insurance coverage
Note. ** p < .001

Standardized
Factor Loadings

SE

.90**
.83**
.78**
.61**

.02
.02
.03
.04

.97**
.79**
.68**
.65**

.02
.03
.04
.04

.94**
.93**
.80**
.74**

.01
.01
.03
.03

.87**
.87**
.76**
.62**

.02
.02
.03
.04
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Appendix C
Table 3
Descriptives and Bivariate Correlations for the Total Sample
Scale

1

1. Perceived Effectiveness

-

2. Knowledge About PrEP

.43**

-

3. PrEP Stigma

-.13*

-.14**

-

4. Treatment Attributes

-.12**

-.07

.49**

-

.11*

-.01

-.07

-.07

-

.24**

.19**

-.33**

5. AHBS Perceived Benefits

2

3

4

5

M

SD

α

4.85 1.12 .83

6. AHBS Perceived Barriers
-.03
.03
Note. * p < .05, ** p < .01, *** p < .001, a p = .05.

4.32 1.48 .80
2.93 1.48 .88
3.62 1.48 .83
4.99 .84

.73

2.29 1.06 .63
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Appendix D
Figure 1
Phases of Item Deletion

Phase 1
Communalities (range: .42-.5)
Items Deleted (n = 8)
Items: 8, 14, 21, 22, 49, 54, 56, 68

Phase 2
Items that did not load at least .5 on their primary factor
Items Deleted (n = 18) by Primary Factor:
Factor 1: 40, 18, 26, 66, 20, 55
Factor 2: 53
Factor 3: 17, 16, 6
Factor 4: 33, 28, 34, 70, 48, 24, 25, 69

Phase 3
Items that cross-loaded >.25 on a secondary factor
Items Deleted (n = 9) by Primary Factor:
Factor 1: 47, 46, 39, 19, 23, 42, 52, 37, 67
Factors 2, 3, and 4: N/A

Phase 4
Items identified during Pre-CFA by modification indices
for removal (n = 16): 1, 2, 3, 5, 7, 10, 13, 15, 35, 38, 45,
51, 57, 59, 62, 63
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